Volume 5.27 | Jul 16

Mesenchymal Cell News 5.27 July 16, 2013
Mesenchymal Cell News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  Mesenchymal Cell News on Twitter
 
TOP STORY
Injecting Iron Supplement Lets Scientists Track Transplanted Stem Cells
A new, noninvasive technique for tracking stem cells after transplantation – developed by a cross-disciplinary team of radiologists, chemists, statisticians and materials scientists a – could help surgeons determine whether a procedure to repair injured or worn-out knees is successful. [Press release from the Stanford University School of Medicine discussing online prepublication in Radiology] Press Release | Abstract
Learn More - Reduce Costs Associated With Collecting And Culturing Cells By Using Frozen Primary Cells
 
PUBLICATIONS (Ranked by impact factor of the journal)
Bmp2 Gene in Osteoblasts of Periosteum and Trabecular Bone Links Bone Formation to Vascularization and Mesenchymal Stem Cells
Researchers generated a new Bmp2 conditional knock-out allele without a neo cassette and removed the Bmp2 gene in osteoblasts (Bmp2-cKOob) using the 3.6Col1a1-Cre transgenic model. Bones of Bmp2-cKOob mice are thinner, with increased brittleness. Osteoblast activity is reduced as reflected in reduced bone formation rate, and failure to differentiate to a mature mineralizing stage. [J Cell Sci] Abstract

Cross-Talk between EGF and BMP9 Signaling Pathways Regulates the Osteogenic Differentiation of Mesenchymal Stem Cells
Scientists investigated if epidermal growth factor (EGF) signaling cross-talks with BMP9 and regulates BMP9-induced osteogenic differentiation. They found that EGF potentiates BMP9-induced early and late osteogenic markers of mesenchymal stem cells in vitro, which can be effectively blunted by epidermal growth factor receptor inhibitors Gefitinib and Erlotinib or receptor tyrosine kinase inhibitors AG-1478 and AG-494 in a dose- and time-dependent manner. [J Cell Mol Med] Abstract | Full Article

Isolation Method and Xeno-Free Culture Conditions Influence Multipotent Differentiation Capacity of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
Wharton’s jelly (WJ) explants and enzymatically dissociated WJ cells were cultured in a defined, xeno-free (XF) medium for mesenchymal stem cells (MSCs). The MSC phenotype of WJ explant- and pellet-derived cells, isolated and expanded in the MSC XF medium, was proven based on the expression of CD44/CD73/CD90/CD105 surface markers and osteo-/adipo-/chondrogenic multipotent differentiation potential, which differed according to the isolation method and/or passage number. [Stem Cell Res Ther] Abstract | Full Article

Mesenchymal Stromal Cells Augment CD4+ and CD8+ T-Cell Proliferation through a CCL2 Pathway
Researchers showed that mesenchymal stromal cells (MSC) have both suppressive and stimulatory functions toward T cells after stimulation with anti-CD3/CD28 beads or in an mixed lymphocyte reaction. This depended on the ratio of MSC to responder T cells, with low numbers of MSC increasing and higher numbers inhibiting T-cell proliferation. [Cytotherapy] Abstract

Effect of Mechanical Stretch on the Proliferation and Differentiation of BMSCs from Ovariectomized Rats
To explore the correlation between mechanical stress and osteoblastic differentiation of bone mesenchymal stem cells (BMSCs) in osteoporosis, investigators built an osteoporosis model in ovariectomized rats, and then investigated proliferation, alkaline phosphatase activity, and the expression of osteoblastic genes in BMSCs under mechanical stress of 5 and 10% elongation, using the Flexercell Strain system. [Mol Cell Biochem] Abstract

Chemical Nanoroughening of Ti40Nb Surfaces and Its Effect on Human Mesenchymal Stromal Cell Response
Samples of low modulus beta-type Ti40Nb and cp2-Ti were chemically treated with 98% H2SO4 + 30% H2O2 solution. The in vitro analyses clearly indicated that the chemical treatment accelerates the adhesion and spreading of human mesenchymal stromal cells, increases the metabolic activity, and the enzyme activity of tissue non-specific alkaline phosphatase. [J Biomed Mater Res B Appl Biomater] Abstract

Emulsion Electrospun Nanofibers as Substrates for Cardiomyogenic Differentiation of Mesenchymal Stem Cells
The potential of cardiomyogenic differentiation of human mesenchymal stem cells (hMSCs) on emulsion electrospun scaffold containing poly(l-lactic acid)-co-poly-(e-caprolactone), gelatin and vascular endothelial growth factor (PLCL/GV) was investigated in this study. The proliferation of hMSCs showed that 73.4% higher cell proliferation on PLCL/GV scaffolds than that on PLCL scaffold after 20 days of cell culture. [J Mater Sci Mater Med] Abstract

Short-Term Spheroid Formation Enhances the Regenerative Capacity of Adipose-Derived Stem Cells by Promoting Stemness, Angiogenesis, and Chemotaxis
Investigators examined whether adipose-derived stem cells (ASCs) exhibit superior regenerative capacity by expanding them in monolayers following short-term spheroid formation. Spheroid-derived ASCs retained the expression pattern of cell surface markers and adipogenic/osteogenic differentiation capabilities of ASCs constantly cultured in monolayers. [Stem Cell Transl Med] Abstract

Identification and Isolation of Small CD44-Negative Mesenchymal Stem/Progenitor Cells from Human Bone Marrow Using Elutriation and Polychromatic Flow Cytometry
Scientists used polychromatic flow cytometry and counterflow centrifugal elutriation to identify a phenotypically distinct population of mesenchymal stem/progenitor cells (MSPCs) within human bone marrow. The MSPC activity resided within a population of rare, small CD45CD73+CD90+CD105+ cells that lack CD44, an antigen that is highly expressed on culture-expanded mesenchymal stem/stromal cells. [Stem Cells Transl Med] Abstract

LNGFR+THY-1+VCAM-1hi+ Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem Cells
Researchers report an improved prospective clonal isolation technique and revealed that the combination of three cell-surface markers (LNGFR, THY-1, and VCAM-1) allows for the selection of highly enriched clonogenic cells. Clonal characterization of LNGFR+THY-1+ cells demonstrated cellular heterogeneity among the clones. [Stem Cell Rep] Abstract | Graphical Abstract | Full Article

Request Your Free Wallchart: Mesenchymal Stem Cells (A Nature Reviews Molecular Cell Biology Collaboration)
 
REVIEWS
Composite Tissue Allotransplantation and Dysregulation in Tissue Repair and Regeneration: A Role for Mesenchymal Stem Cells
Insights gained from new studies with mesenchymal stem cells (MSCs) on composite allografts, advances in tissue regeneration reported in other MSC-based clinical studies, as well as consideration of newly described capacities of MSCs, may provide new regenerative based strategies for the care of composite tissue allografts. [Front Immunol] Abstract

Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.
 
INDUSTRY NEWS
American CryoStem Granted IRB Approval for Adipose Derived Stem Cell Processing Protocols
American CryoStem Corporation announced that its protocols for the processing of Stromal Vascular Fraction and culturing of mesenchymal stem cells from autologous adipose tissue have been approved by the Institutional Review Board (IRB) of the International Cell Surgical Society. [American CryoStem Corporation] Press Release

Bioventus Names Alessandra Pavesio New Chief Science Officer
Bioventus, a leader in active orthopaedic healing, announced that Alessandra Pavesio will join the company Aug. 5 as its new Chief Science Officer. A recognized opinion leader in regenerative medicine, Pavesio revolutionized cartilage regeneration by conceiving and developing the first third-generation autologous chondrocyte implantation technology to reach the market. [Bioventus] Press Release

Cellular Biomedicine Group Appoints Director of Medical Research
Cellular Biomedicine Group, Inc. announced the appointment of Maxwell Wang, M.D., PhD, as Director of Medical Research. Dr. Wang is an orthopedic surgeon with over 10 years of experience in academic research focused on mesenchymal stem cells and bone cells. [PR Newswire Association LLC] Press Release

From our sponsor: Learn about assays for cord blood. Download the free technical bulletin.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW Stem Cell Society Singapore Symposium 2013
November 18-19, 2013
Singapore, Singapore

Visit our events page to see a complete list of events in the mesenchymal cell community.
 
JOB OPPORTUNITIES
NEW PhD Studentship – Mechanobiology of Stem Cells (Queen Mary University of London)

Postdoctoral Position – Cardiopulmonary Molecular Biology (Hannover Medical School)

Two PhD Students and One Postdoc – Molecular Cell Biology and Hematopoiesis (Sanquin)

PhD Positions – Tissue Engineering (Eight European Research Institutes)

Postdoctoral Fellow – Visualization of Gene Expression Promoting Mesenchymal Stem Cell Tropism (Johns Hopkins University School of Medicine)

Director of Cell Processing Facility (S L Collins Associates, Inc.)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.
Learn more about Mesenchymal Cell News: Archives | Events | Contact Us